Sciencast Management LP acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 6,050 shares of the company’s stock, valued at approximately $461,000.
Several other large investors also recently bought and sold shares of HSIC. Laurel Grove Capital LLC raised its holdings in shares of Henry Schein by 39.6% during the fourth quarter. Laurel Grove Capital LLC now owns 17,241 shares of the company’s stock worth $1,205,000 after purchasing an additional 4,891 shares during the last quarter. Janus Henderson Group PLC raised its holdings in shares of Henry Schein by 92.1% during the third quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock worth $230,777,000 after purchasing an additional 1,349,333 shares during the last quarter. Neuberger Berman Group LLC raised its holdings in shares of Henry Schein by 95.9% during the third quarter. Neuberger Berman Group LLC now owns 2,475,058 shares of the company’s stock worth $202,930,000 after purchasing an additional 1,211,743 shares during the last quarter. AXA raised its holdings in shares of Henry Schein by 513.5% during the fourth quarter. AXA now owns 624,368 shares of the company’s stock worth $43,631,000 after purchasing an additional 522,600 shares during the last quarter. Finally, Catalyst Capital Advisors LLC purchased a new position in shares of Henry Schein during the third quarter worth $287,000. Institutional investors and hedge funds own 98.54% of the company’s stock.
Several research analysts recently issued reports on the stock. JPMorgan Chase reissued a “neutral” rating and set a $77.00 target price (down previously from $79.00) on shares of Henry Schein in a report on Thursday, February 15th. Leerink Swann raised shares of Henry Schein from a “market perform” rating to an “outperform” rating and set a $75.00 target price for the company in a report on Wednesday. Barclays assumed coverage on shares of Henry Schein in a report on Thursday, March 8th. They set an “equal weight” rating and a $71.00 target price for the company. Deutsche Bank assumed coverage on shares of Henry Schein in a report on Friday, December 8th. They set a “buy” rating and a $79.00 target price for the company. Finally, Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Tuesday, March 6th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and nine have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $82.31.
HSIC traded down $1.04 on Friday, reaching $66.78. The stock had a trading volume of 1,281,305 shares, compared to its average volume of 1,600,655. Henry Schein, Inc. has a 12-month low of $62.56 and a 12-month high of $93.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.76 and a current ratio of 1.45. The stock has a market capitalization of $10,465.02, a price-to-earnings ratio of 18.55, a PEG ratio of 1.66 and a beta of 1.05.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 20th. The company reported $0.97 EPS for the quarter, hitting analysts’ consensus estimates of $0.97. The business had revenue of $3.32 billion during the quarter, compared to analysts’ expectations of $3.30 billion. Henry Schein had a net margin of 3.26% and a return on equity of 19.70%. The company’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.94 earnings per share. equities research analysts forecast that Henry Schein, Inc. will post 4.09 earnings per share for the current year.
WARNING: This news story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/04/07/sciencast-management-lp-buys-new-position-in-henry-schein-inc-hsic.html.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.